Vilma Methner
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Vilma Methner
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
14
| Public Company | Medical/Nursing Services | 14 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Vilma Methner
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
enGene, Inc.
 enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | Biotechnology | Director/Board Member | |
International Federation of Pharmaceutical Manufacturers
 International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | Biotechnology | Corporate Officer/Principal | |
Nestlé Deutschland AG
 Nestlé Deutschland AG Food: Specialty/CandyConsumer Non-Durables Nestlé Deutschland AG makes ice creams and frozen desserts. It also offers baby, sports, breakfast, ready to mix kitchen helper, drinks, and sweets. The company was founded in 1839 and is headquartered in Frankfurt am Main, Germany. | Food: Specialty/Candy | Director/Board Member | |
Oboronprom United Industrial Corp. JSC
 Oboronprom United Industrial Corp. JSC Aerospace & DefenseElectronic Technology Oboronprom United Industrial Corp. JSC operates as a holding company with interests in civilian and military helicopters manufacturing. It operates as a diversified industrial-investment group in the engineering and technologies sectors. The company was founded in 2002 and is headquartered in Moscow, the Russian Federation. | Aerospace & Defense | Corporate Officer/Principal | |
| CERMAQ GROUP AS | Agricultural Commodities/Milling | Director of Finance/CFO | |
| Moscow State University Lomonosov | College/University | Undergraduate Degree | |
B·R·A·H·M·S GmbH
 B·R·A·H·M·S GmbH Miscellaneous Commercial ServicesCommercial Services B·R·A·H·M·S GmbH engages in the development and manufacture of novel diagnostic testing procedures. Its products include B·R·A·H·M·S PCT (Procalcitonin), MR-proADM (Mid-regional proadrenomedullin), Copeptin proAVP, Neopterin, and KRYPTOR Instruments. The company was founded in 1994 and is headquartered in Hennigsdorf, Germany. | Miscellaneous Commercial Services | Founder | |
| Technical University of Berlin | College/University | Undergraduate Degree | |
| Norwegian School of Economics & Business Administration | College/University | Undergraduate Degree | |
BC Brandenburg Capital GmbH
 BC Brandenburg Capital GmbH Investment ManagersFinance BC Brandenburg Capital GmbH (BC GmbH) is a venture capital investment firm and a majority-owned subsidiary of ILB-Investitionsbank des Landes Brandenburg, the promotional bank for the State of Brandenburg in the east of Germany. BC GmbH was established in 2000 and is headquartered in Potsdam near Berlin, with an office in Frankfurt an der Oder, on the German-Polish border. The firm manages a series of venture capital funds, and invests a combination of private and public funds. | Investment Managers | Private Equity Investor | |
| Philipps University of Marburg | College/University | Doctorate Degree | |
Xellia Pharmaceuticals AS
 Xellia Pharmaceuticals AS Pharmaceuticals: MajorHealth Technology Xellia Pharmaceuticals AS develops, manufactures, and supplies pharmaceutical drugs. The firm engages in the filed of biotechnology, synthetic organic chemistry development, and analytical development. The company was founded in 1946 and is headquartered in Oslo, Norway. | Pharmaceuticals: Major | Director of Finance/CFO | |
| University of Potsdam | College/University | Masters Business Admin | |
BFB Brandenburg Kapital GmbH
 BFB Brandenburg Kapital GmbH Investment ManagersFinance BFB Brandenburg Kapital GmbH invests in small and middle market technology orientated companies located in the state of Brandenburg, Germany, in the form of direct investments and silent partnership. It invests only together with at least one private investor. | Investment Managers | Corporate Officer/Principal | |
Avelas Biosciences, Inc.
 Avelas Biosciences, Inc. Medical/Nursing ServicesHealth Services Avelas Biosciences, Inc. develops integrated suite of therapeutic and imaging agents for treatment of cancer. It develops AVB-620, an intravenously administered in vivo fluorescent protease activatable peptide that detects, marks, and diagnoses cancer. The company was founded by Yon Chien Tsien, Quyen T. Nguyen and Michael A. Whitney in 2008 and is headquartered in La Jolla, CA. | Medical/Nursing Services | Director/Board Member | |
| DEUTSCHE BIOTECH INNOVATIV AG | Financial Conglomerates | Chief Executive Officer Director of Finance/CFO | |
Generium ZAO
 Generium ZAO Pharmaceuticals: MajorHealth Technology Generium ZAO is a biotechnology company based in Moscow, Russian Federation. The company is a leader in the Russian pharmaceutical market for orphan diseases and has its own R&D park capable of developing any biotech product from molecule design to commercial production. Generium's manufacturing facilities comply with international GMP standards and produce a unique variety of biotech products, including biomedical cell products. The private company offers job opportunities and is dedicated to biotechnological research and development. | Pharmaceuticals: Major | Director/Board Member | |
International Biotech Center Generium, LLC
 International Biotech Center Generium, LLC Miscellaneous Commercial ServicesCommercial Services International Biotech Center Generium, LLC operates as a Russian scientific research company. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Togliatti Academy of Management | College/University | Graduate Degree | |
| Turenfabrik Brunegg AG | Director/Board Member | ||
| Klaus Jakob & Partner AG | Corporate Officer/Principal | ||
| Stählin Consulting | Founder | ||
Actigen Ltd.
 Actigen Ltd. BiotechnologyHealth Technology Actigen Ltd. provides biological products. The private company is based in Cambridge, UK. | Biotechnology | Director/Board Member | |
| WCG Consulting AG | Chairman | ||
| EXACT THERAPEUTICS | Biotechnology | Director of Finance/CFO | |
Valtema Holding AG
 Valtema Holding AG Financial ConglomeratesFinance Valtema Holding AG is an investment holding Swiss company. The private company is based in Brunegg, Switzerland. | Financial Conglomerates | Director/Board Member | |
| Bracolux Leuchten AG | Chairman | ||
| Bracolux AG | Chairman | ||
| Hbl Finanz AG | Director/Board Member | ||
| BG OST-SÜD Bürgschaftsgenossenschaft für KMU | Director/Board Member | ||
| Pensionskasse des Schweizerischen Bauernverbandes | Director/Board Member | ||
Vue Group AG
 Vue Group AG Specialty TelecommunicationsCommunications Part of Sanoptis AG, Vue Group AG offers video telematics and fleet tracking solutions. The company is based in Baar, Switzerland. Vue Group was acquired by Sanoptis AG on September 30, 2022. | Specialty Telecommunications | Director/Board Member | |
| Augenklinik Vue Center AG | Director/Board Member | ||
| Bobex AG | Chairman | ||
SolMic AG
 SolMic AG Pharmaceuticals: MajorHealth Technology SolMic AG engages in the development and management of patents. It also sells and distributes nutraceutical, agroceutical, and cosmeceutical products. The company was founded on December 18, 2008 and is headquartered in Stans, Switzerland. | Pharmaceuticals: Major | Chairman | |
| Kiwanis Club of Uster | Corporate Officer/Principal | ||
| Deutsche Gemeinnützige Gesellschaft Integrative Onkologie Und | Director/Board Member | ||
Kauri CAB Management GmbH
 Kauri CAB Management GmbH Investment ManagersFinance Kauri CAB Management GmbH operates as a asset management company. The company was founded by Andreas Baltrusch and is headquartered in Berlin, Germany. | Investment Managers | Chief Executive Officer | |
| The Institute For Quality & Efficiency In Healthcare | Director/Board Member | ||
| German Society For Regulatory Affairs | President | ||
Belano Medical AG
 Belano Medical AG BiotechnologyHealth Technology Belano Medical AG is a leading German company in the development and production of innovative active substances for the human microbiome. The private company is based in Hennigsdorf, Germany. The company's focus is on microbiotic active substances and microbiome products. The CEO of the company is Bernd Wegener. | Biotechnology | Chief Executive Officer | |
| Lusee AG | Chairman | ||
Bundesverband der Pharmazeutischen Industrie eV
 Bundesverband der Pharmazeutischen Industrie eV Pharmaceuticals: MajorHealth Technology Bundesverband der Pharmazeutischen Industrie eV operates as a German pharmaceutical company. The private company is based in Berlin, Germany. The company was founded in 1951. The CEO is Hans-Georg Feldmeier. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
AdrenoMed AG
 AdrenoMed AG Pharmaceuticals: MajorHealth Technology AdrenoMed AG develops a drug to decrease mortality in severe sepsis. The company was founded by Bernd Wegener, Gerald Heinz Möller and Andreas Bergmann in 2009 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Founder | |
| ORGANOBALANCE Medical AG | Chief Executive Officer | ||
| CFO for Hire AS | Chairman | ||
| Affitech Research AS | Director of Finance/CFO |
Statistik
International
| Schweiz | 18 |
| Deutschland | 17 |
| Norwegen | 7 |
| Russland | 6 |
| Vereinigte Staaten | 4 |
Sektoral
| Health Technology | 14 |
| Consumer Services | 7 |
| Finance | 6 |
| Commercial Services | 3 |
| Consumer Non-Durables | 2 |
Operativ
| Director/Board Member | 32 |
| Chairman | 13 |
| Corporate Officer/Principal | 13 |
| Chief Executive Officer | 11 |
| Founder | 8 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Vilma Methner
- Unternehmensverbindungen
